403PPHASE II STUDY EVALUATING ORAL VINORELBINE AS A SINGLE-AGENT AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST CANCER PATIENTS WITH BONE METASTASES (NORBREAST-228 TRIAL): FIRST EFFICACY RESULTS.
暂无分享，去创建一个
E. Espinosa | M. Benasso | M. Błasińska-Morawiec | G. Steger | C. Marth | M. Pecherstorfer | N. Tubiana-Mathieu | P. Bougnoux | C. Veyret | S. Protsenko | A. Ardizzoia | F. Giotta | O. Switsers | G. Villanova | A. Domínguez | J. Dorca | I. Głogowska | A. Manikhas | N. Dobrovolskaya | S. García